Fidelity Advisor Biotechnology Fund (FBTTX) is a publicly traded company in the Financial Services sector, operating within the Asset Management industry.
FBTTX has IPO date of 2000-12-27, listed on the NASDAQ, a market capitalization of $1.65B.
The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.
